VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (5)
An exome sequencing study of Moebius syndrome including atypical cases reveals an individual with CFEOM3A and a TUBB3 mutation.
First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients.
Polypodium
Regulation of therapeutic resistance in cancers by receptor tyrosine kinases.
Targeting 2-oxoglutarate dehydrogenase for cancer treatment.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting 2-oxoglutarate dehydrogenase for cancer treatment.
Targeting 2-oxoglutarate dehydrogenase for cancer treatment. Am J Cancer Res. 2022; 12(4):1436-1455.
View in:
PubMed
authors with profiles
MIEN-CHIE HUNG